Physician profile
Gary Wayne Jay
NPI 1063839793
$5,824.15
in general payments reported to CMS, 2019-2025
8 companies · $27.58 in 2025
The $27.58 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,242 · 2021: $164 · 2022: $184 · 2023: $19.56 · 2024: $187 · 2025: $27.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $5,119.03 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $183.94 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $164.01 | 2021 | |
| Pfizer INC. | $141.65 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $122.68 | 2019 | |
| Abbvie INC. | $45.70 | 2024 | |
| Livanova USA, INC. | $27.58 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Collegium Pharmaceutical, INC. | $19.56 | 2023 | Xtampza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Jay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.